Panel Discussion: Evaluating Clinical Potential of Different NK Subtypes
Time: 2:30 pm
day: Day 2 - Track B - PM
Details:
- Discuss how different NK subtypes perform against various cancer types and disease models
- How do different NK phenotypes influence therapeutic outcomes?
- Is it best to have a homogenous or heterogenous NK product?
